<!DOCTYPE html><html><head><meta charSet="utf-8" class="next-head"/><title class="next-head">ALiEM Cards</title><meta name="viewport" content="initial-scale=1.0, width=device-width" class="next-head"/><meta charset="utf-8" class="next-head"/><meta http-equiv="x-ua-compatible" content="ie=edge" class="next-head"/><link rel="apple-touch-icon" sizes="180x180" href="/static/Favicons/apple-touch-icon.png" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-32x32.png" sizes="32x32" class="next-head"/><link rel="icon" type="image/png" href="/static/Favicons/favicon-16x16.png" sizes="16x16" class="next-head"/><link rel="mask-icon" href="/static/Favicons/safari-pinned-tab.svg" color="#00b092" class="next-head"/><link rel="shortcut icon" href="/static/Favicons/favicon.ico" class="next-head"/><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans" class="next-head"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js" as="script"/><link rel="preload" href="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js" as="script"/><link rel="preload" href="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" as="script"/><link rel="preload" href="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" as="script"/><link rel="preload" href="/_next/static/chunks/styles.9b76ae77785496d5351a.js" as="script"/><link rel="preload" href="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" as="script"/><link rel="stylesheet" href="/_next/static/css/commons.b3e9c004.chunk.css"/><link rel="stylesheet" href="/_next/static/css/styles.0fc85b66.chunk.css"/></head><body><div id="__next"><div data-reactroot=""><div><div class="header" role="banner"><div class="header__logo"><a href="/"><img src="/static/logo.svg"/></a></div><div class="header__nav-button"><button class="hamburger hamburger__squeeze"><span class="hamburger__box"><span class="hamburger__inner"></span></span></button></div><nav class="header__nav header__nav--closed" role="navigation"><ul><li><a href="/cards/">Cards</a></li><li><a href="/categories/">Categories</a></li><li><a href="/about/">About</a></li></ul></nav></div><div class="search"><div class="search__input" role="search"><input type="text" placeholder="Search" aria-label="Search for cards" value=""/></div></div></div><main class="content container" role="main"><article role="article"><h1>Initial Pain Management Options</h1><div class="card"><div class="card__meta"><div><strong>Authors: </strong>Nick Koch, MD, Sergey Motov, MD</div><div><strong>Updated:</strong> <!-- -->10/23/2015</div></div><div class="card__content"><h1 id="initial-ed-pain-management-options-in-ed">Initial ED Pain Management Options in ED</h1>
<h2 id="acetaminophen-and-nsaids">Acetaminophen and NSAIDs</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Acetaminophen</td>
<td>500-1000 mg PO</td>
</tr>
<tr>
<td>| 1000 mg IV over 15 minutes</td>
<td></td>
</tr>
<tr>
<td>| 650 mg PR</td>
<td></td>
</tr>
<tr>
<td>Ibuprofen</td>
<td>400-600 mg PO</td>
</tr>
<tr>
<td>Naproxen</td>
<td>250-500 mg PO</td>
</tr>
<tr>
<td>Ketorolac</td>
<td>10 mg PO or 10-15 mg IV</td>
</tr>
<tr>
<td>Indomethacin</td>
<td>25-50 mg PO</td>
</tr>
</tbody></table>
<h2 id="non-opioids">Non-Opioids</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Lidocaine 1%</td>
<td><strong>Local/regional anesthetic</strong><br>Max: 4 mg/kg; 7 mg/kg with epinephrine</td>
</tr>
<tr>
<td>| <strong>Intra-articular</strong><br>5-20 mL</td>
<td></td>
</tr>
<tr>
<td>Lidocaine 2%</td>
<td><strong>Local/regional anesthetic</strong><br>Max: 4 mg/kg; 7 mg/kg with epinephrine</td>
</tr>
<tr>
<td>Lidoderm 5% patch</td>
<td>Apply on skin</td>
</tr>
<tr>
<td>Bupivacaine 0.25-0.5%</td>
<td><strong>Local/regional anesthetic</strong><br>Max dose: 2.5 mg/kg; 3 mg/kg with epinephrine</td>
</tr>
<tr>
<td>Triamcinolone</td>
<td><strong>Intra-articular</strong><br>2.5-40 mg</td>
</tr>
<tr>
<td>Gabapentin</td>
<td>100-300 mg PO</td>
</tr>
<tr>
<td>Pregabalin</td>
<td>25 mg PO</td>
</tr>
<tr>
<td>Ketamine - <em>Subdissociative dose</em></td>
<td>0.3 mg/kg IV in 100 mL NS over 10 min</td>
</tr>
<tr>
<td>| <strong>Continuous infusion</strong>: 0.15 mg/kg/hr IV (100 mg in 100 mL NS)</td>
<td></td>
</tr>
<tr>
<td>| 1 mg/kg IN (no more than 1 mL per nostril)</td>
<td></td>
</tr>
</tbody></table>
<h2 id="opioids">Opioids</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Oxycodone (5 mg tablet)</td>
<td>1-2 tabs PO</td>
</tr>
<tr>
<td>Hydrocodone (5 mg tablet)</td>
<td>1-2 tabs PO</td>
</tr>
<tr>
<td>Oxycodone/acetaminophen (5/325 mg tablet)</td>
<td>1-2 tabs PO</td>
</tr>
<tr>
<td>Hydrocodone/acetaminophen (5/325 mg tablet)</td>
<td>1-2 tabs PO</td>
</tr>
<tr>
<td>Hydrocodone/ibuprofen (2.5/200 mg tablet)</td>
<td>1-2 tabs PO</td>
</tr>
<tr>
<td>Morphine IR (15 mg tablet)</td>
<td>1-2 tabs PO</td>
</tr>
<tr>
<td>Hydromorphone</td>
<td><strong>Weight-based:</strong> 0.015 mg/kg IV titrate Q 15 min</td>
</tr>
<tr>
<td>| <strong>Fixed dose:</strong> 1 mg IV titrate Q 10-15 min</td>
<td></td>
</tr>
<tr>
<td>| 2-4 mg IM</td>
<td></td>
</tr>
<tr>
<td>| 2-4 mg PO</td>
<td></td>
</tr>
<tr>
<td>Morphine</td>
<td><strong>Weight-based:</strong> 0.1 mg/kg IV titrate Q 20 min</td>
</tr>
<tr>
<td>| <strong>Fixed dose:</strong> 5 mg IV titrate Q 10-15 min</td>
<td></td>
</tr>
<tr>
<td>| <strong>Fixed dose infusion:</strong> 10 mg IV in 100 mL NS over 10 min titrate Q 20-30 min</td>
<td></td>
</tr>
<tr>
<td>| 10-20 mg nebulized with 3 mL NS</td>
<td></td>
</tr>
<tr>
<td>Fentanyl</td>
<td><strong>Weight-based:</strong> 1-1.5 mcg/kg IV in 100 mL NS over 5-10 min</td>
</tr>
<tr>
<td>| <strong>Fixed dose:</strong> 50-100 mcg IV in 100 mL NS over 10 min</td>
<td></td>
</tr>
<tr>
<td>| 1-2 mcg/kg IN (no more than 1 mL per nostril)</td>
<td></td>
</tr>
<tr>
<td>| 2-4 mcg/kg nebulized</td>
<td></td>
</tr>
<tr>
<td>Naloxone</td>
<td>(for opioid-induced pruritus) 0.25-0.5 mcg/kg/hr IV (2 mg naloxone in 100 mL  NS)</td>
</tr>
</tbody></table>
<h1 id="pain-syndromes">Pain Syndromes</h1>
<h2 id="abdominal-pain-non-traumatic-">Abdominal Pain (non-traumatic)</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Ketorolac</td>
<td>10-15 mg IV</td>
</tr>
<tr>
<td>Rescue Opioids</td>
<td>Morphine or Fentanyl IV</td>
</tr>
</tbody></table>
<h2 id="abdominal-pain-traumatic-">Abdominal Pain (traumatic)</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Opioids</td>
<td>Morphine or Fentanyl IV</td>
</tr>
<tr>
<td>Acetaminophen</td>
<td>1 g IV over 15 min (adjunct to opioids)</td>
</tr>
</tbody></table>
<h2 id="back-pain-acute-">Back Pain (acute)</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>NSAID</td>
<td>Ibuprofen or naproxen</td>
</tr>
<tr>
<td>Methocarbamol</td>
<td>1500 mg PO</td>
</tr>
<tr>
<td>Diazepam</td>
<td>5 mg PO</td>
</tr>
</tbody></table>
<h2 id="back-pain-chronic-">Back Pain (chronic)</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Gabapentin</td>
<td>100-300 mg PO</td>
</tr>
<tr>
<td>Pregabalin</td>
<td>25 mg PO</td>
</tr>
<tr>
<td>Lidoderm 5% Patch</td>
<td>No more than 4 patches in 24 hr</td>
</tr>
</tbody></table>
<h2 id="dental-pain">Dental Pain</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>NSAID</td>
<td>Ibuprofen or naproxen</td>
</tr>
<tr>
<td>Dental Blocks</td>
<td>5 mL of Lidocaine (1-2%) <strong>or</strong><br> 2 mL of Bupivacaine (0.25-0.5%)</td>
</tr>
</tbody></table>
<h2 id="headache">Headache</h2>
<h3 id="oral">Oral</h3>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>NSAID</td>
<td>Ibuprofen or naproxen</td>
</tr>
<tr>
<td>Butalbital/ acetaminophen/caffeine<br>(50/325/40 mg)</td>
<td>1-2 tabs PO</td>
</tr>
<tr>
<td>Metoclopramide</td>
<td>10 mg PO</td>
</tr>
</tbody></table>
<h3 id="parenteral-in-preferred-order-">Parenteral (in preferred order)</h3>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Metoclopramide</td>
<td>10 mg IV (Slow drip over 10-15 min)</td>
</tr>
<tr>
<td>Diphenhydramine</td>
<td>25-50 mg IV</td>
</tr>
<tr>
<td>Prochlorperazine</td>
<td>10 mg IV</td>
</tr>
<tr>
<td>Chlorpromazine</td>
<td>0.1 mg/kg IV</td>
</tr>
<tr>
<td>Sumatriptan</td>
<td>6 mg SQ, repeat with 12 mg SQ (after 1 h)</td>
</tr>
<tr>
<td>Dihydroergotamine</td>
<td>0.25 mg IV, repeat with 1 mg (after 1 h)</td>
</tr>
<tr>
<td>Valproate</td>
<td>300-1000 mg IV (over 30 min)</td>
</tr>
<tr>
<td>Magnesium</td>
<td>2 gm IV (30-60 min)</td>
</tr>
<tr>
<td>Droperidol</td>
<td>1-2.5 mg IV <br>2.5-8 mg IM</td>
</tr>
<tr>
<td>Haloperidol</td>
<td>2.5-5 mg IV</td>
</tr>
</tbody></table>
<h2 id="regional-nerve-blocks">Regional Nerve Blocks</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Paracervical block</td>
<td>5 mL of Lidocaine (1-2%) <strong>or</strong><br>2-3 mL of Bupivacaine (0.25-0.5%)</td>
</tr>
<tr>
<td>Occipital nerve block</td>
<td>5 mL of Lidocaine (1-2%) <strong>or</strong><br>2-3 mL of Bupivacaine (0.25-0.5%)</td>
</tr>
</tbody></table>
<h2 id="musculoskeletal-pain-non-traumatic-">Musculoskeletal Pain (non-traumatic)</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>NSAID</td>
<td>Ibuprofen, naproxen, or indomethacin</td>
</tr>
<tr>
<td>Local/Regional Blocks</td>
<td>Lidocaine or bupivacaine Â± epinephrine</td>
</tr>
<tr>
<td>Neuropathic Pain</td>
<td>Gabapentin 100 mg PO<br>Pregabalin 25 mg PO</td>
</tr>
<tr>
<td>NSAID</td>
<td>Ibuprofen, naproxen, or indomethacin</td>
</tr>
<tr>
<td>Lidoderm 5% patch</td>
<td>Apply on skin</td>
</tr>
</tbody></table>
<h2 id="renal-colic">Renal Colic</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Ketorolac</td>
<td>10-15 mg IV</td>
</tr>
<tr>
<td>Rescue Opioids</td>
<td>Morphine or Fentanyl IV</td>
</tr>
</tbody></table>
<h2 id="sickle-cell-pain-crisis">Sickle Cell Pain Crisis</h2>
<h3 id="intravenous-iv-">Intravenous (IV)</h3>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Opioids</td>
<td>Morphine, fentanyl, or hydromorphone</td>
</tr>
<tr>
<td>Ketorolac</td>
<td>10-15 mg IV</td>
</tr>
</tbody></table>
<h3 id="subcutaneous-sq-">Subcutaneous (SQ)</h3>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Morphine</td>
<td>0.1 mg/kg or 5 mg SQ fixed dose with titration Q 10-15 min</td>
</tr>
<tr>
<td>Hydromorphone</td>
<td>1-1.5 mg SQ with titration Q 15 min</td>
</tr>
</tbody></table>
<h3 id="intranasal-in-nebulized">Intranasal (IN) / Nebulized</h3>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Fentanyl</td>
<td>1-2 mcg/kg IN titrate Q 5-10 min</td>
</tr>
<tr>
<td>Fentanyl</td>
<td>2-4 mcg/kg nebulized single dose</td>
</tr>
</tbody></table>
<p><em>Intramuscular (IM) route is DISCOURAGED!</em></p>
<h2 id="trauma-burns">Trauma &amp; Burns</h2>
<table>
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
</tr>
</thead>
<tbody><tr>
<td>Local/Regional Blocks</td>
<td>Lidocaine or bupivacaine Â± epinephrine</td>
</tr>
<tr>
<td>Opioids</td>
<td>Morphine or Fentanyl</td>
</tr>
<tr>
<td>Ketorolac</td>
<td>10-15 mg IV</td>
</tr>
<tr>
<td>Acetaminophen</td>
<td>1 g IV over 15 min (adjunct to opioids/NSAIDS/ketamine)</td>
</tr>
<tr>
<td>Ketamine<br><em>Subdissociative dose</em></td>
<td>0.3 mg/kg IV in 100 mL NS over 10 min<br><strong>Continuous infusion</strong>: 0.15 mg/kg/hr IV (100 mg in 100 mL NS)<br><strong>Intrnasal</strong> 1 mg/kg (no more than 1 mL per nostril)</td>
</tr>
</tbody></table>
<h2 id="opiate-tolerant-patient-or-refractory-intractable-pain">Opiate-Tolerant Patient or Refractory/Intractable Pain</h2>
<p>Consider subdissociative dosing of ketamine.</p>
<h2 id="references">References</h2>
<ul>
<li>Andolfatto G, Willman E, Joo D. Intranasal ketamine for analgesia in the emergency department: a prospective observational series. Acad Emerg Med. 2013; 20(10):1050-4. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/24127709">Pubmed</a>]</li>
<li>Bartfield JM, Flint RD, McErlean M, Broderick J. Nebulized fentanyl for relief of abdominal pain.. Acad Emerg Med. 2003; 10(3):215-8. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/12615585">Pubmed</a>]</li>
<li>Beaudoin FL, Lin C, Guan W, Merchant RC. Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial.. Acad Emerg Med. 2014; 21(11):1193-202. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25377395">Pubmed</a>]</li>
<li>Borland M, Jacobs I, King B, O&#39;brien D. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med. 2007;49(3):335-40. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17067720">Pubmed</a>]</li>
<li>Chang AK, Bijur PE, Campbell CM, Murphy MK, Gallagher EJ. Safety and efficacy of rapid titration using 1mg doses of intravenous hydromorphone in emergency department patients with acute severe pain: the &quot;1+1&quot; protocol. Ann Emerg Med. 2009;54(2):221-5. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18996618">Pubmed</a>]</li>
<li>Curtis KM, Henriques HF, Fanciullo G, Reynolds CM, Suber F. A fentanyl-based pain management protocol provides early analgesia for adult trauma patients. J Trauma. 2007;63(4):819-26. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18090011">Pubmed</a>]</li>
<li>Friedman BW, Esses D, Solorzano C, et al. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med. 2008;52(4):399-406. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18006188">Pubmed</a>]</li>
<li>Galinski M, Dolveck F, Combes X, et al. Management of severe acute pain in emergency settings: ketamine reduces morphine consumption. Am J Emerg Med. 2007;25(4):385-90. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/17499654">Pubmed</a>]</li>
<li>Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med. 2010;56(1):1-6. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20045576">Pubmed</a>]</li>
<li>Leong LB, Kelly AM. Are butyrophenones effective for the treatment of primary headache in the emergency department?. CJEM. 2011;13(2):96-104. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/21435315">Pubmed</a>]</li>
<li>Lvovschi V, Aubrun F, Bonnet P, et al. Intravenous morphine titration to treat severe pain in the ED. Am J Emerg Med. 2008;26(6):676-82. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/18606320">Pubmed</a>]</li>
<li>Miller JP, Schauer SG, Ganem VJ, Bebarta VS. Low-dose ketamine vs morphine for acute pain in the ED: a randomized controlled trial. Am J Emerg Med. 2015;33(3):402-8. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25624076">Pubmed</a>]</li>
<li>Motov S, Rockoff B, Cohen V, et al. Intravenous Subdissociative-Dose Ketamine Versus Morphine for Analgesia in the Emergency Department: A Randomized Controlled Trial. Ann Emerg Med. 2015;66(3):222-229.e1. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/25817884">Pubmed</a>]</li>
<li>Patanwala AE, Keim SM, Erstad BL. Intravenous opioids for severe acute pain in the emergency department. Ann Pharmacother. 2010;44(11):1800-9. [<a href="http://www.ncbi.nlm.nih.gov/pubmed/20978218">Pubmed</a>]</li>
<li>Thomas SH. Emergency Department Analgesia, An Evidence-Based Guide. Cambridge University Press; 2008.</li>
<li>Yeaman F, Meek R, Egerton-warburton D, Rosengarten P, Graudins A. Sub-dissociative-dose intranasal ketamine for moderate to severe pain in adult emergency department patients. Emerg Med Australas. 2014;26(3):237-42.[<a href="http://www.ncbi.nlm.nih.gov/pubmed/24712757">Pubmed</a>]</li>
<li>Strayer RJ, Motov SM, Nelson LS. Something for pain: Responsible opioid use in emergency medicine. Am J Emerg Med. 2017;35(2):337-341. [<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=27802876">PubMed</a>]</li>
</ul>
</div></div></article></main><div class="footer" role="contentinfo"><div class="container"><div class="row footer__cc"><div class="footer__cc-image"><a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="creative-commons" src="/static/by-nc-nd.svg"/></a></div><div class="footer__cc-text">This work is licensed under a<!-- --> <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License</a>.</div></div><div class="row footer__links"><div><a href="/contact/">Contact</a></div><div><a href="/contact/">Get Involved</a></div><div><a href="/about/">About</a></div></div><div class="row row--centered"><div class="container footer__disclaimer">ALiEM Cards content is intended for use by healthcare professionals. Users of this site should exercise their own clinical judgment as to the reliability and accuracy of its information. Non-healthcare-professionals who use this site do so at their own risk. Content on this site should not be construed as medical advice. Users should always confer with medical profoessionals regarding decisions about medications, evaluations and other medical treatments.</div></div></div></div></div></div><script>__NEXT_DATA__ = {"props":{"pageProps":{"card":{"slug":"pain-management","title":"Initial Pain Management Options","authors":["Nick Koch, MD","Sergey Motov, MD"],"categories":[{"slug":"pharmacology","name":"Pharmacology"}],"created":"2015/10/23","updated":null,"body":"\n# Initial ED Pain Management Options in ED\n\n## Acetaminophen and NSAIDs\n\n| Medication    | Dose                       |\n| ------------- | -------------------------- |\n| Acetaminophen | 500-1000 mg PO             |\n|               | 1000 mg IV over 15 minutes |\n|               | 650 mg PR                  |\n| Ibuprofen     | 400-600 mg PO              |\n| Naproxen      | 250-500 mg PO              |\n| Ketorolac     | 10 mg PO or 10-15 mg IV    |\n| Indomethacin  | 25-50 mg PO                |\n\n## Non-Opioids\n\n| Medication                        | Dose                                                                           |\n| --------------------------------- | ------------------------------------------------------------------------------ |\n| Lidocaine 1%                      | **Local/regional anesthetic**\u003cbr\u003eMax: 4 mg/kg; 7 mg/kg with epinephrine        |\n|                                   | **Intra-articular**\u003cbr\u003e5-20 mL                                                 |\n| Lidocaine 2%                      | **Local/regional anesthetic**\u003cbr\u003eMax: 4 mg/kg; 7 mg/kg with epinephrine        |\n| Lidoderm 5% patch                 | Apply on skin                                                                  |\n| Bupivacaine 0.25-0.5%             | **Local/regional anesthetic**\u003cbr\u003eMax dose: 2.5 mg/kg; 3 mg/kg with epinephrine |\n| Triamcinolone                     | **Intra-articular**\u003cbr\u003e2.5-40 mg                                               |\n| Gabapentin                        | 100-300 mg PO                                                                  |\n| Pregabalin                        | 25 mg PO                                                                       |\n| Ketamine - _Subdissociative dose_ | 0.3 mg/kg IV in 100 mL NS over 10 min                                          |\n|                                   | **Continuous infusion**: 0.15 mg/kg/hr IV (100 mg in 100 mL NS)                |\n|                                   | 1 mg/kg IN (no more than 1 mL per nostril)                                     |\n\n## Opioids\n\n| Medication                                  | Dose                                                                              |\n| ------------------------------------------- | --------------------------------------------------------------------------------- |\n| Oxycodone (5 mg tablet)                     | 1-2 tabs PO                                                                       |\n| Hydrocodone (5 mg tablet)                   | 1-2 tabs PO                                                                       |\n| Oxycodone/acetaminophen (5/325 mg tablet)   | 1-2 tabs PO                                                                       |\n| Hydrocodone/acetaminophen (5/325 mg tablet) | 1-2 tabs PO                                                                       |\n| Hydrocodone/ibuprofen (2.5/200 mg tablet)   | 1-2 tabs PO                                                                       |\n| Morphine IR (15 mg tablet)                  | 1-2 tabs PO                                                                       |\n| Hydromorphone                               | **Weight-based:** 0.015 mg/kg IV titrate Q 15 min                                 |\n|                                             | **Fixed dose:** 1 mg IV titrate Q 10-15 min                                       |\n|                                             | 2-4 mg IM                                                                         |\n|                                             | 2-4 mg PO                                                                         |\n| Morphine                                    | **Weight-based:** 0.1 mg/kg IV titrate Q 20 min                                   |\n|                                             | **Fixed dose:** 5 mg IV titrate Q 10-15 min                                       |\n|                                             | **Fixed dose infusion:** 10 mg IV in 100 mL NS over 10 min titrate Q 20-30 min    |\n|                                             | 10-20 mg nebulized with 3 mL NS                                                   |\n| Fentanyl                                    | **Weight-based:** 1-1.5 mcg/kg IV in 100 mL NS over 5-10 min                      |\n|                                             | **Fixed dose:** 50-100 mcg IV in 100 mL NS over 10 min                            |\n|                                             | 1-2 mcg/kg IN (no more than 1 mL per nostril)                                     |\n|                                             | 2-4 mcg/kg nebulized                                                              |\n| Naloxone                                    | (for opioid-induced pruritus) 0.25-0.5 mcg/kg/hr IV (2 mg naloxone in 100 mL  NS) |\n\n# Pain Syndromes\n\n## Abdominal Pain (non-traumatic)\n\n| Medication     | Dose                     |\n| -------------- | ------------------------ |\n| Ketorolac      | 10-15 mg IV              |\n| Rescue Opioids | Morphine or Fentanyl IV  |\n\n## Abdominal Pain (traumatic)\n\n| Medication     | Dose                                      |\n| -------------- | ----------------------------------------- |\n| Opioids        | Morphine or Fentanyl IV                   |\n| Acetaminophen  | 1 g IV over 15 min (adjunct to opioids)   |\n\n## Back Pain (acute)\n\n| Medication    | Dose                      |\n| ------------- | ------------------------- |\n| NSAID         | Ibuprofen or naproxen     |\n| Methocarbamol | 1500 mg PO                |\n| Diazepam      | 5 mg PO                   |\n\n## Back Pain (chronic)\n\n| Medication        | Dose                            |\n| ----------------- | ------------------------------- |\n| Gabapentin        | 100-300 mg PO                   |\n| Pregabalin        | 25 mg PO                        |\n| Lidoderm 5% Patch | No more than 4 patches in 24 hr |\n\n## Dental Pain\n\n| Medication     | Dose                                                                |\n| -------------- | ------------------------------------------------------------------- |\n| NSAID          | Ibuprofen or naproxen                                               |\n| Dental Blocks  | 5 mL of Lidocaine (1-2%) **or**\u003cbr\u003e 2 mL of Bupivacaine (0.25-0.5%) |\n\n## Headache\n\n### Oral\n\n| Medication                                            | Dose                     |\n| ----------------------------------------------------- | ------------------------ |\n| NSAID                                                 | Ibuprofen or naproxen    |\n| Butalbital/ acetaminophen/caffeine\u003cbr\u003e(50/325/40 mg)  | 1-2 tabs PO              |\n| Metoclopramide                                        | 10 mg PO                 |\n\n### Parenteral (in preferred order)\n\n| Medication        | Dose                                      |\n| ----------------- | ----------------------------------------- |\n| Metoclopramide    | 10 mg IV (Slow drip over 10-15 min)       |\n| Diphenhydramine   | 25-50 mg IV                               |\n| Prochlorperazine  | 10 mg IV                                  |\n| Chlorpromazine    | 0.1 mg/kg IV                              |\n| Sumatriptan       | 6 mg SQ, repeat with 12 mg SQ (after 1 h) |\n| Dihydroergotamine | 0.25 mg IV, repeat with 1 mg (after 1 h)  |\n| Valproate         | 300-1000 mg IV (over 30 min)              |\n| Magnesium         | 2 gm IV (30-60 min)                       |\n| Droperidol        | 1-2.5 mg IV \u003cbr\u003e2.5-8 mg IM               |\n| Haloperidol       | 2.5-5 mg IV                               |\n\n## Regional Nerve Blocks\n\n| Medication            | Dose                                                                 |\n| --------------------- | -------------------------------------------------------------------- |\n| Paracervical block    | 5 mL of Lidocaine (1-2%) **or**\u003cbr\u003e2-3 mL of Bupivacaine (0.25-0.5%) |\n| Occipital nerve block | 5 mL of Lidocaine (1-2%) **or**\u003cbr\u003e2-3 mL of Bupivacaine (0.25-0.5%) |\n\n## Musculoskeletal Pain (non-traumatic)\n\n| Medication            | Dose                                          |\n| --------------------- | --------------------------------------------- |\n| NSAID                 | Ibuprofen, naproxen, or indomethacin          |\n| Local/Regional Blocks | Lidocaine or bupivacaine Â± epinephrine        |\n| Neuropathic Pain      | Gabapentin 100 mg PO\u003cbr\u003ePregabalin 25 mg PO   |\n| NSAID                 | Ibuprofen, naproxen, or indomethacin          |\n| Lidoderm 5% patch     | Apply on skin                                 |\n\n## Renal Colic\n\n| Medication     | Dose                     |\n| -------------- | ------------------------ |\n| Ketorolac      | 10-15 mg IV              |\n| Rescue Opioids | Morphine or Fentanyl IV  |\n\n## Sickle Cell Pain Crisis\n\n### Intravenous (IV)\n\n| Medication     | Dose                                 |\n| -------------- | ------------------------------------ |\n| Opioids        | Morphine, fentanyl, or hydromorphone |\n| Ketorolac      | 10-15 mg IV                          |\n\n### Subcutaneous (SQ)\n\n| Medication     | Dose                                                       |\n| -------------- | ---------------------------------------------------------- |\n| Morphine       | 0.1 mg/kg or 5 mg SQ fixed dose with titration Q 10-15 min |\n| Hydromorphone  | 1-1.5 mg SQ with titration Q 15 min                        |\n\n### Intranasal (IN) / Nebulized\n\n| Medication     | Dose                             |\n| -------------- | -------------------------------- |\n| Fentanyl       | 1-2 mcg/kg IN titrate Q 5-10 min |\n| Fentanyl       | 2-4 mcg/kg nebulized single dose |\n\n_Intramuscular (IM) route is DISCOURAGED!_\n\n## Trauma \u0026 Burns\n\n| Medication                         | Dose                                                                                                                                                              |\n| ---------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Local/Regional Blocks              | Lidocaine or bupivacaine Â± epinephrine                                                                                                                            |\n| Opioids                            | Morphine or Fentanyl                                                                                                                                              |\n| Ketorolac                          | 10-15 mg IV                                                                                                                                                       |\n| Acetaminophen                      | 1 g IV over 15 min (adjunct to opioids/NSAIDS/ketamine)                                                                                                           |\n| Ketamine\u003cbr\u003e_Subdissociative dose_ | 0.3 mg/kg IV in 100 mL NS over 10 min\u003cbr\u003e**Continuous infusion**: 0.15 mg/kg/hr IV (100 mg in 100 mL NS)\u003cbr\u003e**Intrnasal** 1 mg/kg (no more than 1 mL per nostril) |\n\n## Opiate-Tolerant Patient or Refractory/Intractable Pain\n\nConsider subdissociative dosing of ketamine.\n\n## References\n- Andolfatto G, Willman E, Joo D. Intranasal ketamine for analgesia in the emergency department: a prospective observational series. Acad Emerg Med. 2013; 20(10):1050-4. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/24127709)]\n- Bartfield JM, Flint RD, McErlean M, Broderick J. Nebulized fentanyl for relief of abdominal pain.. Acad Emerg Med. 2003; 10(3):215-8. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/12615585)]\n- Beaudoin FL, Lin C, Guan W, Merchant RC. Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial.. Acad Emerg Med. 2014; 21(11):1193-202. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/25377395)]\n- Borland M, Jacobs I, King B, O'brien D. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med. 2007;49(3):335-40. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/17067720)]\n- Chang AK, Bijur PE, Campbell CM, Murphy MK, Gallagher EJ. Safety and efficacy of rapid titration using 1mg doses of intravenous hydromorphone in emergency department patients with acute severe pain: the \"1+1\" protocol. Ann Emerg Med. 2009;54(2):221-5. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/18996618)]\n- Curtis KM, Henriques HF, Fanciullo G, Reynolds CM, Suber F. A fentanyl-based pain management protocol provides early analgesia for adult trauma patients. J Trauma. 2007;63(4):819-26. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/18090011)]\n- Friedman BW, Esses D, Solorzano C, et al. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med. 2008;52(4):399-406. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/18006188)]\n- Galinski M, Dolveck F, Combes X, et al. Management of severe acute pain in emergency settings: ketamine reduces morphine consumption. Am J Emerg Med. 2007;25(4):385-90. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/17499654)]\n- Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT. A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med. 2010;56(1):1-6. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/20045576)]\n- Leong LB, Kelly AM. Are butyrophenones effective for the treatment of primary headache in the emergency department?. CJEM. 2011;13(2):96-104. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/21435315)]\n- Lvovschi V, Aubrun F, Bonnet P, et al. Intravenous morphine titration to treat severe pain in the ED. Am J Emerg Med. 2008;26(6):676-82. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/18606320)]\n- Miller JP, Schauer SG, Ganem VJ, Bebarta VS. Low-dose ketamine vs morphine for acute pain in the ED: a randomized controlled trial. Am J Emerg Med. 2015;33(3):402-8. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/25624076)]\n- Motov S, Rockoff B, Cohen V, et al. Intravenous Subdissociative-Dose Ketamine Versus Morphine for Analgesia in the Emergency Department: A Randomized Controlled Trial. Ann Emerg Med. 2015;66(3):222-229.e1. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/25817884)]\n- Patanwala AE, Keim SM, Erstad BL. Intravenous opioids for severe acute pain in the emergency department. Ann Pharmacother. 2010;44(11):1800-9. [[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/20978218)]\n- Thomas SH. Emergency Department Analgesia, An Evidence-Based Guide. Cambridge University Press; 2008.\n- Yeaman F, Meek R, Egerton-warburton D, Rosengarten P, Graudins A. Sub-dissociative-dose intranasal ketamine for moderate to severe pain in adult emergency department patients. Emerg Med Australas. 2014;26(3):237-42.[[Pubmed](http://www.ncbi.nlm.nih.gov/pubmed/24712757)]\n- Strayer RJ, Motov SM, Nelson LS. Something for pain: Responsible opioid use in emergency medicine. Am J Emerg Med. 2017;35(2):337-341. [[PubMed](https://www.ncbi.nlm.nih.gov/pubmed/?term=27802876)]\n"}}},"page":"/card","pathname":"/card","query":{"slug":"pain-management"},"buildId":"1~ee3OFOv6kXxZUoU_eCb","nextExport":true};__NEXT_LOADED_PAGES__=[];__NEXT_REGISTER_PAGE=function(r,f){__NEXT_LOADED_PAGES__.push([r, f])}</script><script async="" id="__NEXT_PAGE__/card" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/card.js"></script><script async="" id="__NEXT_PAGE__/_app" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_app.js"></script><script async="" id="__NEXT_PAGE__/_error" src="/_next/static/1~ee3OFOv6kXxZUoU_eCb/pages/_error.js"></script><script src="/_next/static/runtime/webpack-89179faa512dd01fbb62.js" async=""></script><script src="/_next/static/chunks/commons.ce4c8f8c27f9b1d9e256.js" async=""></script><script src="/_next/static/chunks/styles.9b76ae77785496d5351a.js" async=""></script><script src="/_next/static/runtime/main-cfdfd101abde4b1d3f2a.js" async=""></script></body></html>